Evidence map›Paper›PMID 41174222›Full record

ReviewNature aging2025

Adapting health, economic and social policies to address population aging in China.

Evandro F Fang, Yuan Fang, Guobing Chen, He-Ling Wang, Jianying Zhang, Chenkai Wu, Jing Liao, Chenglong Xie, Xiaoting Liu, Kan Wang and 26 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A combined artificial intelligence-wet lab approach identifies a pivotal role of the NADAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. NADAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Evandro F Fang *Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway. e.f.fang@medisin.uio.no.ORCID http://orcid.org/0000-0003-0355-7202
Yuan Fang *Promenta Research Center, Department of Psychology, University of Oslo, Oslo, Norway. yuanf@uio.no.
Guobing ChenInstitute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.ORCID http://orcid.org/0000-0002-2401-6168
He-Ling WangDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.ORCID http://orcid.org/0000-0002-8920-1487
Jianying ZhangDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.ORCID http://orcid.org/0000-0001-8161-7536
Chenkai WuGlobal Health Research Center, Duke Kunshan University, Kunshan, China.ORCID http://orcid.org/0000-0002-2256-0653
Jing LiaoDepartment of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.
Chenglong XieDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
Xiaoting LiuSchool of Public Affairs, Zhejiang University, Hangzhou, China.
Kan WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yang LiuSchool of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID http://orcid.org/0000-0001-8320-2756
Guang YangBioengineering Department and Imperial-X, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-7344-7733
Qian WangDepartment of Geriatrics, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Long-Tao HeResearch Institute of Social Development, Southwestern University of Finance and Economics, Chengdu, China.
Jun LiState Key laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry and molecular Biology, Institute of Basic medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID http://orcid.org/0000-0002-0179-4151
Hou-Zao ChenState Key laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry and molecular Biology, Institute of Basic medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID http://orcid.org/0000-0001-6805-3182
Lin KangDepartment of Geriatrics, Peking Union Medical College Hospital, Beijing, China.
Yawen JiangSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.ORCID http://orcid.org/0000-0002-0498-0662
Huanxing SuKey Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Hong JiangDepartment of Neurology, The Third Xiangya Hospital of Central South University, Changsha, China.
Na HeSchool of Public Health, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-5560-5312
Jun TaoDepartment of Hypertension and Vascular Disease the First Affiliated Hospital Sun Yat-Sen University, Guangzhou, China.ORCID http://orcid.org/0000-0002-2226-765X
Sean Xiao LengJohns Hopkins Center on Aging and Immune Remodeling, Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-2690-8055
Richard C SiowAgeing Research at King's (ARK) and School of Cardiovascular and Metabolic Medicine & Sciences, King's British Heart Foundation Centre of Research Excellence, Faculty of Life Sciences & Medicine, King's College London, London, UK.ORCID http://orcid.org/0000-0003-4603-9763
Chunrong LiuSchool of International Relations and Public Affairs, Fudan University, Shanghai, China.
Hafiz T A KhanPublic Health Group, College of Nursing, Midwifery and Healthcare, University of West London, London, UK.
Yuanli LiuSchool of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Hisaya KatoDepartment of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.ORCID http://orcid.org/0000-0002-5964-6856
Takashi SasakiCenter for Supercentenarian Medical Research, Keio University of School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-6275-046X
Jong In KimKorean Society of Health and Welfare, Sejong, Republic of Korea.ORCID http://orcid.org/0000-0002-8960-485X
Andrea Britta MaierHealthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0001-7206-1724
Lin ZhangDepartment of Epidemiology and Preventive Medicine, The School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0002-2064-8440
Lene Juel RasmussenCenter for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6864-963X
Jean WooDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.ORCID http://orcid.org/0000-0001-7593-3081
Jing WuDepartment of Sociology and Work Science, University of Gothenburg, Gothenburg, Sweden. jing.wu@gu.se.
Huachun ZouShanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People's Republic of China. zouhuachun@fudan.edu.cn.ORCID http://orcid.org/0000-0002-8161-7576

Funding

Cure Alzheimer's Fund (Alzheimer's Disease Research Foundation) 282952Cure Alzheimer's Fund (Alzheimer's Disease Research Foundation) 284930Kreftforeningen (Norwegian Cancer Society) 207819National Natural Science Foundation of China (National Science Foundation of China) 81971327NordForsk 119986Norges Forskningsråd (Research Council of Norway) 262175Norges Forskningsråd (Research Council of Norway) 334361Office of the Royal Society IEC/NSFC/211235
6 · The paper itself

Abstract

Despite its rapid economic rise over the past four decades, China now grapples with the challenge of accommodating and supporting its expanding aging population. In 2020, 18% of its population were over age 60, and 2.5% were over age 80, projected to rise to 39% and 10%, respectively, by 2050. This demographic shift places China at the forefront of diverse individual, familial and societal challenges. Here, we review these challenges in the context of emerging breakthroughs in basic and translational research, shifts in healthcare paradigms, evolving socioeconomic and political dynamics, and policy innovations. We synthesize China's current policies toward promoting healthy longevity in the general population, focusing on social health insurance, long-term care insurance, community and home-based care and palliative care, as well as gerontological research, public health prevention, nutritional and medical interventions, while identifying strengths and gaps. Finally, we propose suggestions to promote a more inclusive, resilient and happier aging society within China's distinctive sociopolitical and cultural context.

Indexed as

AgingHealth PolicyPopulation DynamicsPublic PolicyAgedAged, 80 and overChinaHumansMiddle AgedSocioeconomic Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.